nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoversetamide—Oedema—Triamcinolone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Gadoversetamide—Vertigo—Dexamethasone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Gadoversetamide—Vertigo—Betamethasone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Gadoversetamide—Syncope—Betamethasone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Gadoversetamide—Syncope—Dexamethasone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Gadoversetamide—Arrhythmia—Prednisone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Gadoversetamide—Haematuria—Methotrexate—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Gadoversetamide—Shock—Triamcinolone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Gadoversetamide—Insomnia—Prednisolone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Gadoversetamide—Shock—Methylprednisolone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Gadoversetamide—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Gadoversetamide—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Gadoversetamide—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Gadoversetamide—Epistaxis—Methotrexate—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Gadoversetamide—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Gadoversetamide—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Gadoversetamide—Mental disorder—Prednisone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Gadoversetamide—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Gadoversetamide—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Gadoversetamide—Malnutrition—Prednisone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Gadoversetamide—Erythema—Prednisone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Gadoversetamide—Convulsion—Betamethasone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Gadoversetamide—Convulsion—Dexamethasone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Gadoversetamide—Hypertension—Betamethasone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Gadoversetamide—Hypertension—Dexamethasone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Gadoversetamide—Myalgia—Betamethasone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Gadoversetamide—Myalgia—Dexamethasone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Gadoversetamide—Anxiety—Betamethasone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Gadoversetamide—Anxiety—Dexamethasone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Gadoversetamide—Discomfort—Betamethasone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Gadoversetamide—Discomfort—Dexamethasone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Gadoversetamide—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Gadoversetamide—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Gadoversetamide—Pain—Prednisolone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Gadoversetamide—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Gadoversetamide—Pharyngitis—Methotrexate—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Gadoversetamide—Vision blurred—Prednisone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Gadoversetamide—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Gadoversetamide—Oedema—Betamethasone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Gadoversetamide—Oedema—Dexamethasone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Gadoversetamide—Insomnia—Triamcinolone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Gadoversetamide—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Gadoversetamide—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Gadoversetamide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Gadoversetamide—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Gadoversetamide—Shock—Dexamethasone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Gadoversetamide—Shock—Betamethasone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Gadoversetamide—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Gadoversetamide—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Gadoversetamide—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Gadoversetamide—Agitation—Prednisone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Gadoversetamide—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Gadoversetamide—Tachycardia—Betamethasone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Gadoversetamide—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Gadoversetamide—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Gadoversetamide—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Gadoversetamide—Malaise—Prednisone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Gadoversetamide—Vertigo—Prednisone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Gadoversetamide—Eye disorder—Methotrexate—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Gadoversetamide—Syncope—Prednisone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Gadoversetamide—Tinnitus—Methotrexate—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Gadoversetamide—Anorexia—Betamethasone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Gadoversetamide—Anorexia—Dexamethasone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Gadoversetamide—Urticaria—Prednisolone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Gadoversetamide—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Gadoversetamide—Fatigue—Triamcinolone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Gadoversetamide—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Gadoversetamide—Pain—Triamcinolone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Gadoversetamide—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Gadoversetamide—Hypotension—Dexamethasone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Gadoversetamide—Hypotension—Betamethasone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Gadoversetamide—Angiopathy—Methotrexate—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Gadoversetamide—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Gadoversetamide—Convulsion—Prednisone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Gadoversetamide—Hypertension—Prednisone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Gadoversetamide—Chills—Methotrexate—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Gadoversetamide—Myalgia—Prednisone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Gadoversetamide—Arthralgia—Prednisone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Gadoversetamide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Gadoversetamide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Gadoversetamide—Anxiety—Prednisone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Gadoversetamide—Insomnia—Dexamethasone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Gadoversetamide—Insomnia—Betamethasone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Gadoversetamide—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Gadoversetamide—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Gadoversetamide—Discomfort—Prednisone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Gadoversetamide—Mental disorder—Methotrexate—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Gadoversetamide—Erythema—Methotrexate—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Gadoversetamide—Malnutrition—Methotrexate—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Gadoversetamide—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Gadoversetamide—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Gadoversetamide—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Gadoversetamide—Urticaria—Triamcinolone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Gadoversetamide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Gadoversetamide—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Gadoversetamide—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Gadoversetamide—Oedema—Prednisone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Gadoversetamide—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Gadoversetamide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Gadoversetamide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Gadoversetamide—Back pain—Methotrexate—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Gadoversetamide—Fatigue—Betamethasone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Gadoversetamide—Fatigue—Dexamethasone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Gadoversetamide—Shock—Prednisone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Gadoversetamide—Pain—Dexamethasone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Gadoversetamide—Pain—Betamethasone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Gadoversetamide—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Gadoversetamide—Tachycardia—Prednisone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Gadoversetamide—Skin disorder—Prednisone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Gadoversetamide—Vision blurred—Methotrexate—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Gadoversetamide—Anorexia—Prednisone—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Gadoversetamide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Gadoversetamide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Gadoversetamide—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Gadoversetamide—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Gadoversetamide—Malaise—Methotrexate—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Gadoversetamide—Vertigo—Methotrexate—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Gadoversetamide—Urticaria—Betamethasone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Gadoversetamide—Urticaria—Dexamethasone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Gadoversetamide—Dizziness—Prednisolone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Gadoversetamide—Asthenia—Triamcinolone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Gadoversetamide—Abdominal pain—Betamethasone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Gadoversetamide—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Gadoversetamide—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Gadoversetamide—Body temperature increased—Betamethasone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Gadoversetamide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Gadoversetamide—Insomnia—Prednisone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Gadoversetamide—Paraesthesia—Prednisone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Gadoversetamide—Pruritus—Triamcinolone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Gadoversetamide—Cough—Methotrexate—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Gadoversetamide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Gadoversetamide—Convulsion—Methotrexate—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Gadoversetamide—Dyspepsia—Prednisone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Gadoversetamide—Chest pain—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Gadoversetamide—Arthralgia—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Gadoversetamide—Myalgia—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Gadoversetamide—Decreased appetite—Prednisone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Gadoversetamide—Rash—Prednisolone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Gadoversetamide—Dermatitis—Prednisolone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Gadoversetamide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Gadoversetamide—Fatigue—Prednisone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Gadoversetamide—Headache—Prednisolone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Gadoversetamide—Discomfort—Methotrexate—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Gadoversetamide—Constipation—Prednisone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Gadoversetamide—Confusional state—Methotrexate—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Gadoversetamide—Dizziness—Triamcinolone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Gadoversetamide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Gadoversetamide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Gadoversetamide—Asthenia—Betamethasone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Gadoversetamide—Asthenia—Dexamethasone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Gadoversetamide—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Gadoversetamide—Nausea—Prednisolone—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Gadoversetamide—Pruritus—Betamethasone—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Gadoversetamide—Pruritus—Dexamethasone—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Gadoversetamide—Skin disorder—Methotrexate—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Gadoversetamide—Vomiting—Triamcinolone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Gadoversetamide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Gadoversetamide—Rash—Triamcinolone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Anorexia—Methotrexate—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Rash—Methylprednisolone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Urticaria—Prednisone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Headache—Triamcinolone—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Headache—Methylprednisolone—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Abdominal pain—Prednisone—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Body temperature increased—Prednisone—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Gadoversetamide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Gadoversetamide—Hypotension—Methotrexate—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Gadoversetamide—Dizziness—Betamethasone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Gadoversetamide—Dizziness—Dexamethasone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Gadoversetamide—Insomnia—Methotrexate—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Gadoversetamide—Nausea—Triamcinolone—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Gadoversetamide—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Gadoversetamide—Nausea—Methylprednisolone—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Gadoversetamide—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Gadoversetamide—Somnolence—Methotrexate—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Gadoversetamide—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Gadoversetamide—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Gadoversetamide—Vomiting—Dexamethasone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Gadoversetamide—Vomiting—Betamethasone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Gadoversetamide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Gadoversetamide—Rash—Dexamethasone—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Gadoversetamide—Rash—Betamethasone—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Gadoversetamide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Gadoversetamide—Dermatitis—Betamethasone—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Gadoversetamide—Fatigue—Methotrexate—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Gadoversetamide—Headache—Dexamethasone—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Gadoversetamide—Headache—Betamethasone—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Gadoversetamide—Asthenia—Prednisone—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Gadoversetamide—Pain—Methotrexate—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Gadoversetamide—Pruritus—Prednisone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Gadoversetamide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Gadoversetamide—Diarrhoea—Prednisone—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Gadoversetamide—Nausea—Betamethasone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Gadoversetamide—Nausea—Dexamethasone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Gadoversetamide—Urticaria—Methotrexate—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Dizziness—Prednisone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Gadoversetamide—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Gadoversetamide—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Gadoversetamide—Vomiting—Prednisone—ankylosing spondylitis	0.000982	0.000982	CcSEcCtD
Gadoversetamide—Rash—Prednisone—ankylosing spondylitis	0.000974	0.000974	CcSEcCtD
Gadoversetamide—Dermatitis—Prednisone—ankylosing spondylitis	0.000973	0.000973	CcSEcCtD
Gadoversetamide—Headache—Prednisone—ankylosing spondylitis	0.000968	0.000968	CcSEcCtD
Gadoversetamide—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000951	0.000951	CcSEcCtD
Gadoversetamide—Asthenia—Methotrexate—ankylosing spondylitis	0.000926	0.000926	CcSEcCtD
Gadoversetamide—Nausea—Prednisone—ankylosing spondylitis	0.000918	0.000918	CcSEcCtD
Gadoversetamide—Pruritus—Methotrexate—ankylosing spondylitis	0.000914	0.000914	CcSEcCtD
Gadoversetamide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000884	0.000884	CcSEcCtD
Gadoversetamide—Dizziness—Methotrexate—ankylosing spondylitis	0.000854	0.000854	CcSEcCtD
Gadoversetamide—Vomiting—Methotrexate—ankylosing spondylitis	0.000821	0.000821	CcSEcCtD
Gadoversetamide—Rash—Methotrexate—ankylosing spondylitis	0.000814	0.000814	CcSEcCtD
Gadoversetamide—Dermatitis—Methotrexate—ankylosing spondylitis	0.000813	0.000813	CcSEcCtD
Gadoversetamide—Headache—Methotrexate—ankylosing spondylitis	0.000809	0.000809	CcSEcCtD
Gadoversetamide—Nausea—Methotrexate—ankylosing spondylitis	0.000767	0.000767	CcSEcCtD
